HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
Open Access
- 29 March 2018
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 17 (1) , 1-9
Abstract
Diabetic complications may be associated with impaired time-dependent glycemic control. Therefore, long-term glycemic variability, assessed by variations in haemoglobin A1c (HbA1c), may be a potential risk factor for microvascular complications, such as diabetic peripheral neuropathy (DPN). We investigated the association of HbA1c variability with DPN in patients with type 2 diabetes. In this cross-sectional study, 563 type 2 diabetic patients who had been screened for DPN and undergone quarterly HbA1c measurements during the year preceding enrolment were recruited. DPN was confirmed in patients displaying both clinical manifestations of neuropathy and abnormalities in a nerve conduction evaluation. HbA1c variability was assessed by the coefficient of variation of HbA1c (CV-HbA1c), and the mean of HbA1c (M-HbA1c) was calculated. In addition, medical history and clinical data were collected. Among the recruited patients, 18.1% (n = 102) were found to have DPN, and these patients also presented with a higher CV-HbA1c than the patients without DPN (p < 0.001). The proportion of patients with DPN increased significantly from 6.9% in the first to 19.1% in the second and 28.5% in the third tertile of CV-HbA1c (p for trend < 0.001). After adjusting for initial HbA1c, M-HbA1c and other clinical factors via multiple logistic regression analysis, the odds ratios (ORs) for DPN in the second and third versus those in the first CV-HbA1c tertile were 3.61 (95% CI 1.62–8.04) and 6.48 (2.86–14.72), respectively. The area under the receiver operating characteristic (ROC) curve of CV-HbA1c was larger than that of M-HbA1c, at 0.711 (95% CI 0.659–0.763) and 0.662 (0.604–0.721), respectively. ROC analysis also revealed that the optimal cutoff value of CV-HbA1c to indicate DPN was 15.15%, and its corresponding sensitivity and specificity were 66.67% and 65.73%, respectively. Increased HbA1c variability is closely associated with DPN in type 2 diabetic patients and could be considered as a potent indicator for DPN in these patients.Keywords
Funding Information
- Medical Research Projects of Nantong Technology Bureau (HS2012028, MS22015065)
- Medical Research Project of Health and Family Planning Commission of Jiangsu (QNRC2016408)
This publication has 51 references indexed in Scilit:
- Endoplasmic Reticulum Stress Plays a Key Role in the Pathogenesis of Diabetic Peripheral NeuropathyDiabetes, 2013
- The Relationship Between Brain Volume and Walking Outcomes in Older Adults With and Without Diabetic Peripheral NeuropathyDiabetes Care, 2012
- The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing countryDiabetology & Metabolic Syndrome, 2012
- Variation of Fasting Plasma Glucose: A Predictor of Mortality in Patients with Type 2 DiabetesThe American Journal of Medicine, 2012
- Insulin resistance in the nervous systemTrends in Endocrinology & Metabolism, 2012
- Diabetic Peripheral Neuropathy Is Associated With Increased Arterial Stiffness Without Changes in Carotid Intima–Media Thickness in Type 2 DiabetesDiabetes Care, 2011
- Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetesCardiovascular Diabetology, 2011
- The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patientsDiabetes Research and Clinical Practice, 2011
- Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and TreatmentsDiabetes Care, 2010
- Vascular Risk Factors and Diabetic NeuropathyNew England Journal of Medicine, 2005